Latest Classification of mental disorders Stories
Ushered in amidst a firestorm of controversy, the latest edition of the psychiatrist’s encyclopedia, known as the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders, or DSM-5, may already be out of date.
Later this month, the American Psychiatric Association will release the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders, referred to as DSM-5, and the impending release has been stirring a vigorous debate within the psychological community.
Millions of people could be mislabeled as mentally ill when psychiatry's bible of diagnoses is updated in May.
Mental disorders that emerge in childhood and adolescence, including attention-deficit disorder, depression, anxiety and substance abuse, constitute significant challenges to cognitive, emotional, and social development.
While many small studies have shown a relationship between infertility and psychological distress, reporting a high prevalence of anxiety, mood disorders and depressive symptoms, few have studied the psychological effect of childlessness on a large population basis.
Every new edition of the Diagnostic and Statistical Manual of Mental Disorders stirs up a host of questions and controversies, and the next DSM—the DSM-5, to be published in 2013—is no exception.
Babies who are born premature have a higher risk of developing schizophrenia or other mental disorders later on life, scientists from Sweden and the UK claim in a new study.
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form.
One in every four American adults will have a diagnosable, treatable mental health condition this year.
There are concerns that the revised Diagnostic and Statistical Manual of Mental Disorders (DSM—an internationally recognised classification of mental disorders produced by the American Psychiatric Association), scheduled for publication in May 2013, has been unduly influenced by the pharmaceutical industry despite the APA's instigating a policy of disclosing all financial conflicts of interest.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.